Cite
HARVARD Citation
Shen, M. et al. (2022). Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation. Therapeutic advances in hematology. p. . [Online].